long intergenic non-protein coding RNA 1748Genealiases: []
Q-omics provides the consensus-scored LINC01748 profile across patient tissues and cancer cell-line models. LINC01748 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC01748 is differentially expressed in 13, with the highest sampling consensus in HNSC. Additionally, LINC01748 RNA expression shows 15,253 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight ACC, HNSC, and THYM as cancer lineages where LINC01748 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01748 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01748 survival associations across molecular data types. LINC01748 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01748 RNA expression–survival associations across cancer types. High LINC01748 expression shows unfavorable associations in ACC, DLBC, LIHC and THCA, but favorable associations in UCS and ESCA. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC01748 RNA expression.
This table summarizes LINC01748 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 13. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01748. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01748 shows higher tumor expression in HNSC, COAD, STAD, LUSC, BLCA and KIRP. The HNSC box plot shows higher LINC01748 RNA expression in tumor versus normal tissue (log2 FC = +1.146, t-test p < 0.001).
This table shows molecular features associated with LINC01748 in patient tissues and cancer cell lines. In patient samples, LINC01748 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
